Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 10;22(10):1688.
doi: 10.3390/molecules22101688.

Synthesis of 11C-Labelled Ureas by Palladium(II)-Mediated Oxidative Carbonylation

Affiliations

Synthesis of 11C-Labelled Ureas by Palladium(II)-Mediated Oxidative Carbonylation

Sara Roslin et al. Molecules. .

Abstract

Positron emission tomography is an imaging technique with applications in clinical settings as well as in basic research for the study of biological processes. A PET tracer, a biologically active molecule where a positron-emitting radioisotope such as carbon-11 has been incorporated, is used for the studies. Development of robust methods for incorporation of the radioisotope is therefore of the utmost importance. The urea functional group is present in many biologically active compounds and is thus an attractive target for incorporation of carbon-11 in the form of [11C]carbon monoxide. Starting with amines and [11C]carbon monoxide, both symmetrical and unsymmetrical 11C-labelled ureas were synthesised via a palladium(II)-mediated oxidative carbonylation and obtained in decay-corrected radiochemical yields up to 65%. The added advantage of using [11C]carbon monoxide was shown by the molar activity obtained for an inhibitor of soluble epoxide hydrolase (247 GBq/μmol-319 GBq/μmol). DFT calculations were found to support a reaction mechanism proceeding through an 11C-labelled isocyanate intermediate.

Keywords: 11C-labelling; carbon monoxide; carbon-11; carbonylation; positron emission tomography; urea.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Biologically active ureas.
Scheme 1
Scheme 1
Hypothetical reaction paths for 11C-labelled urea formation.
Scheme 2
Scheme 2
Calculated free energies (kcal/mol) of intermediates along path A in Scheme 1 showing that the path is energetically feasible.

Similar articles

Cited by

References

    1. Wood K.A., Hoskin P.J., Saunders M.I. Positron emission tomography in oncology: A review. Clin. Oncol. 2007;19:237–255. doi: 10.1016/j.clon.2007.02.001. - DOI - PubMed
    1. Rocchi L., Niccolini F., Politis M. Recent imaging advances in neurology. J. Neurol. 2015;262:2182–2194. doi: 10.1007/s00415-015-7711-x. - DOI - PubMed
    1. Boutagy N.E., Sinusas A.J. Recent advances and clinical applications of PET cardiac autonomic nervous system imaging. Curr. Cardiol. Rep. 2017;19 doi: 10.1007/s11886-017-0843-0. - DOI - PMC - PubMed
    1. Langer O. Use of PET Imaging to evaluate transporter-mediated drug-drug interactions. J. Clin. Pharmacol. 2016;56:S143–S156. doi: 10.1002/jcph.722. - DOI - PubMed
    1. Papadimitriou L., Smith-Jones P.M., Sarwar C.M.S., Marti C.N., Yaddanapudi K., Skopicki H.A., Gheorghiade M., Parsey R., Butler J. Utility of positron emission tomography for drug development for heart failure. Am. Heart J. 2016;175:142–152. doi: 10.1016/j.ahj.2016.02.016. - DOI - PubMed

LinkOut - more resources